Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Schedule
All Days
Fri, Aug 25
Sat, Aug 26
Sun, Aug 27
Poster Schedule
Type here to filter the list
Saturday, August 26, 2023
8:00 AM – 6:00 PM
ADT
(001) Exploratory Analysis of Patient Characteristics and Treatment Duration in Patients using Esketamine for Treatment-Resistant Depression: A Large Longitudinal Study Linking Commercial Claims Data to Electronic Medical Records
Favorite
8:00 AM – 6:00 PM
ADT
(002) Assessing The Impact of the Slow-Release Oral Morphine Drug Shortages in Ontario: a Population-Based Time Series Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(003) Survival and drug treatment patterns in multiple myeloma patients exposed to an anti-CD38 monoclonal antibody, a proteasome inhibitor and an immunomodulatory imide drugs
Favorite
8:00 AM – 6:00 PM
ADT
(004) Association of Medication Safety Announcements with topical calcineurin inhibitor Prescribing: A repeated cross-sectional analysis
Favorite
8:00 AM – 6:00 PM
ADT
(005) Low-Value Prescriptions For Injury Hospitalisations: A Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(006) Spontaneous reporting of urinary dysfunction associated with polypharmacy: a case/non-case study
Favorite
8:00 AM – 6:00 PM
ADT
(007) Prescription Ranitidine Use and Population Exposure in Six Canadian Provinces, 1996 to 2019
Favorite
8:00 AM – 6:00 PM
ADT
(008) Association between physician characteristics and antiplatelet medication dispensed to community dwelling New Brunswick older adults following hospital discharge for myocardial infarction between 2009 and 2017
Favorite
8:00 AM – 6:00 PM
ADT
(009) Extent of the Ranitidine Shortage and its Impact on Acid Suppression Drug Utilization in Canada and the United States: an Interrupted Time Series Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(010) Impacts of Tier-3 drug shortages on utilization trends across Canada: A cross-sectional analysis of 3 drug shortages
Favorite
8:00 AM – 6:00 PM
ADT
(011) Assessment of Buprenorphine Dispensing in Texas Following the 2016 Federal-Level Buprenorphine Access Expansion Policies
Favorite
8:00 AM – 6:00 PM
ADT
(012) Medical Use and Combination Drug Therapy Among US Adult Users Of Central Nervous System Stimulants: A Cross-Sectional Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(013) The impact of lidocaine prescribing reduction strategies: a comparison of two national health services in Europe
Favorite
8:00 AM – 6:00 PM
ADT
(014) Use of intra-articular corticosteroid injections among osteoarthritis patients in UK general practice
Favorite
8:00 AM – 6:00 PM
ADT
(015) Publicly funded access to prescription medicines in Brazil from 1998 to 2019
Favorite
8:00 AM – 6:00 PM
ADT
(017) Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents
Favorite
8:00 AM – 6:00 PM
ADT
(018) Primary Care Prescribing of Cardiovascular System Medications (England, 2015-2019): Variation and Associations
Favorite
8:00 AM – 6:00 PM
ADT
(019) Real World Evidence (RWE) Couture: attributes of well-fitting regulatory grade evidence for efficacy decision making
Favorite
8:00 AM – 6:00 PM
ADT
(020) Gender differences in anticancer drugs among patients with Non-Small Cell Lung Cancer in Taiwan
Favorite
8:00 AM – 6:00 PM
ADT
(021) Characteristics of Prescription Drug Fills Using Pharmacy-Pharmacy Benefits Manager (PBM) Discount Programs: The "Goodrx" Model
Favorite
8:00 AM – 6:00 PM
ADT
(022) Assessment of Narrow therapeutic Index Drugs and Associated Drug Related Problems: A Prospective Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(023) Validity of the ISMP Medication Safety Self-Assessment® for Long-Term Care tool in Australian nursing homes
Favorite
8:00 AM – 6:00 PM
ADT
(024) Alopecia Areata Severity and Real-World Treatment Patterns
Favorite
8:00 AM – 6:00 PM
ADT
(025) Monitoring biological treatments for psoriasis in the Brazilian Public Health System: a real-world study
Favorite
8:00 AM – 6:00 PM
ADT
(027) Publicly funded prescription drugs dispensed to community dwelling New Brunswick older adults following hospital discharge for myocardial infarction between 2009 and 2017
Favorite
8:00 AM – 6:00 PM
ADT
(028) Assessment of High-Risk Medications Utilization and Prescribing Patterns among Special Populations using WHO Prescribing Indicators
Favorite
8:00 AM – 6:00 PM
ADT
(029) Early retirement pensioners diagnosed with mental and behavioral disorders caused by psychoactive substances (ICD F11-19 block) in Germany - characterization and utilization of medical rehabilitation
Favorite
8:00 AM – 6:00 PM
ADT
(030) Gender differences in pattern of medication use in the population of Tuscany region, Italy, in 2021
Favorite
8:00 AM – 6:00 PM
ADT
(032) Drug Utilization Evaluation of Narrow Therapeutic Index Drugs in A Tertiary Care Teaching Hospital
Favorite
8:00 AM – 6:00 PM
ADT
(033) Pharmacists’ Perspectives on Facilitators and Barriers to Pharmacist Prescribing for Patients admitted to Hospital within Nova Scotia Health
Favorite
8:00 AM – 6:00 PM
ADT
(034) Trends in Anti-Obesity Drugs Utilization, Spending, and Prices in Medicaid Programs: 1999–2021
Favorite
8:00 AM – 6:00 PM
ADT
(035) Best practice implementation project on handwritten prescription practices in a public hospital in Uasin Gishu County, Kenya
Favorite
8:00 AM – 6:00 PM
ADT
(036) Efficacy of restricted prescribing protocol of sacubitril valsartan in Heart Failure with reduced Ejection Fraction (HFrEF) in a tertiary center in Saudi Arabia
Favorite
8:00 AM – 6:00 PM
ADT
(037) Clinical Characteristics of Patients Prescribed with Dapagliflozin in a Tertiary Care Teaching Hospital in India
Favorite
8:00 AM – 6:00 PM
ADT
(038) A cross-national comparison between Denmark and the US on age-stratified psychotropic trends among youths: 2010-2020
Favorite
8:00 AM – 6:00 PM
ADT
(039) Describing medication changes near end-of-life: Applied example and methodological considerations
Favorite
8:00 AM – 6:00 PM
ADT
(040) Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries with Heart Failure
Favorite
8:00 AM – 6:00 PM
ADT
(041) Factors associated with opioid overdose and dependence: retrospective cohort study with 959,286 patients initiating opioid therapy
Favorite
8:00 AM – 6:00 PM
ADT
(042) The Size Paradox: Comprehensive Data and Better Methods Can Yield Significant Results with Smaller Sample Sizes in Real World Data (Size Doesn’t Always Matter)
Favorite
8:00 AM – 6:00 PM
ADT
(043) Association of Recreational and Medical Cannabis Legalization with Opioid Prescribing and Mortality: A Generalized Difference-In-Difference Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(044) Assigning Defined Daily Doses (DDD) to Anatomical-Therapeutical-Chemical (ATC) codes that were not addressed by the World Health Organization (WHO): the example of antineoplastics and immunomodulating agents
Favorite
8:00 AM – 6:00 PM
ADT
(045) The Impact of the 2016 CDC Guidelines on Opioid Prescribing in Chronic Low Back Pain: An Interrupted Times Series Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(046) An evaluation of commonly available imputation methods useful for RWE research
Favorite
8:00 AM – 6:00 PM
ADT
(047) Complementary and integrative health modalities to prevent utilization of allopathic medications for dysmenorrhea: A prospective interventional study
Favorite
8:00 AM – 6:00 PM
ADT
(048) Antidepressant Adherence Trajectories Before Tamoxifen Initiation and Risk of Subsequent Antidepressant Discontinuation Among US Women with Breast Cancer
Favorite
8:00 AM – 6:00 PM
ADT
(049) Investigating the ability to adhere to cardiometabolic medication properties: a retrospective cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(050) Real-world management and outcomes for newly diagnosed AML patients initiating Venetoclax and hypomethylating agents in US community practice
Favorite
8:00 AM – 6:00 PM
ADT
(051) Utilization of antidepressants in patients with chronic kidney disease: A nationwide cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(052) Assessment of medication adherence and its factors influencing poor medication adherence among psoriasis patients: a cross-sectional study
Favorite
8:00 AM – 6:00 PM
ADT
(053) Blood Pressure Action Sheet and Medication Adherence for Hypertension: A mixed-method study in Yogyakarta, Indonesia
Favorite
8:00 AM – 6:00 PM
ADT
(054) Closing the Gap on Inflammatory Bowel Disease Treatments and the Risk of Cancer: an International Collaboration Combining National Registries with Medical Chart Abstraction
Favorite
8:00 AM – 6:00 PM
ADT
(055) Defining Key Deprescribing Measures From Electronic Health Data: Learnings From A Multisite Data Harmonization Project
Favorite
8:00 AM – 6:00 PM
ADT
(056) Drug Utilization of Biologic Therapy for Inflammatory Bowel Disease Using Data of An Brazilian Healthcare Administrative Database (2008-2021)
Favorite
8:00 AM – 6:00 PM
ADT
(057) Trajectories and predictors of prescription opioid tapering: a retrospective cohort study in Australian primary care
Favorite
8:00 AM – 6:00 PM
ADT
(058) Dosing of cannabinoids associated with an opioid-sparing effect: A systematic review of longitudinal studies
Favorite
8:00 AM – 6:00 PM
ADT
(059) Predictors of nonadherence to antihypertensives among adult initiating cancer treatment
Favorite
8:00 AM – 6:00 PM
ADT
(060) The predictors of exposure to three-drug combinations among older adults in emergency department settings in the US
Favorite
8:00 AM – 6:00 PM
ADT
(061) Psychiatric Prescription Drug Utilization and Related Overdoses Among Commercially Insured Individuals in the United States, 2020
Favorite
8:00 AM – 6:00 PM
ADT
(062) Acne Vulgaris: Disease Severity and Real-World Treatment Patterns
Favorite
8:00 AM – 6:00 PM
ADT
(063) The quality, supply chain, and use of uterotonics in the zone of influence in the Northern region of Ghana – a survey from healthcare providers’ perspective
Favorite
8:00 AM – 6:00 PM
ADT
(064) Exposure to actionable pharmacogenomic medications in a nationally representative insurance claims database
Favorite
8:00 AM – 6:00 PM
ADT
(065) A comprehensive overview of dispensing durations for all drugs applicable in pharmacoepidemiological studies using Danish data
Favorite
8:00 AM – 6:00 PM
ADT
(066) Utility of Procedure Codes in Identifying Use of Long-Acting Cabotegravir in Administrative Claims Data
Favorite
8:00 AM – 6:00 PM
ADT
(067) Exposure Patterns of Immune Checkpoint Inhibitors Among Older Medicare Beneficiaries with Non-Small Cell Lung Cancer
Favorite
8:00 AM – 6:00 PM
ADT
(068) Clinical and Humanistic Impact of Clinical Pharmacist-Initiated Medication Information Services in Psychiatric Patients
Favorite
8:00 AM – 6:00 PM
ADT
(069) Conceptual bases for the standardization of calculation approaches for establishing exposure duration of single drug utilization records in multi-database studies
Favorite
8:00 AM – 6:00 PM
ADT
(070) Evaluation of critical care clinical pharmacist services and Predictors in identifying the medication related problems in critically ill patients in South India- A hospital based interventional study
Favorite
8:00 AM – 6:00 PM
ADT
(071) Determination of Pill-Burden and Its Association with Treatment Burden among Patients with Advanced Stages of Chronic Kidney Disease in Qatar
Favorite
8:00 AM – 6:00 PM
ADT
(072) To Analyze the Utilization Pattern of Antidotes in Poisoned Patients in a Tertiary Care Hospital
Favorite
8:00 AM – 6:00 PM
ADT
(073) Adherence to statins and LDL-cholesterol control: a population-based study using primary care data
Favorite
8:00 AM – 6:00 PM
ADT
(074) Community Pharmacists Knowledge, Attitude, and Practice towards Hypertensive Patient Counseling in the United Arab Emirates
Favorite
8:00 AM – 6:00 PM
ADT
(076) Pharmacist knowledge, attitudes, practice and barriers towards providing health screening services in the community pharmacy
Favorite
8:00 AM – 6:00 PM
ADT
(077) Antipsychotic-Induced Metabolic Syndrome - A Review
Favorite
8:00 AM – 6:00 PM
ADT
(078) A cross-sectional online survey on ivermectin use for prevention and treatment of SARS-CoV-2 infection in a peruvian population
Favorite
8:00 AM – 6:00 PM
ADT
(080) Frequency of potential drug-drug interactions among patients with acute clinical conditions visiting ambulatory patient education center of a tertiary care hospital
Favorite
8:00 AM – 6:00 PM
ADT
(081) Real-World Survival Effectiveness of Edaravone in Amyotrophic Lateral Sclerosis: A Propensity Score Weighted, Registry-based, Canada-wide Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(082) The Utilization Pattern of Glucagon-Like Peptide-1 Receptor Agonist, Dipeptidyl Peptidase-4 Inhibitor, and Sodium Glucose Co-Transporter-2 Inhibitors in Type 2 Diabetes Mellitus in a Tertiary Care Hospital- A Retrospective Study
Favorite
8:00 AM – 6:00 PM
ADT
(083) Trends and Disparities in Access to Oral Childhood Cancer Medicines in High Income and Low and Middle Income Countries, 2015-2020
Favorite
8:00 AM – 6:00 PM
ADT
(084) Treatment Initiation, Time-to-Treatment, Treatment Duration and Treatment Discontinuation of Direct-Acting Antivirals for Hepatitis-C in Manitoba
Favorite
8:00 AM – 6:00 PM
ADT
(085) Long-term use of prescription opioids and mortality: a population based, propensity-weighted cohort study with 767,299 patients initiating therapy
Favorite
8:00 AM – 6:00 PM
ADT
(086) Data Cleaning to Estimate Dosing Frequency of Zoledronic Acid
Favorite
8:00 AM – 6:00 PM
ADT
(087) A Systematic Review of Real-World Treatment Discontinuation of Interferon-free Direct-acting Antivirals in Patients with Hepatitis-C virus
Favorite
8:00 AM – 6:00 PM
ADT
(088) Assessment of medication adherence among patients with acute clinical conditions in a tertiary care hospital
Favorite
8:00 AM – 6:00 PM
ADT
(089) Prescription analysis emphasizing on medication adherence of antibiotics for lower respiratory tract infection
Favorite
8:00 AM – 6:00 PM
ADT
(090) Use of Very Low-Dose Vaginal Estrogens Among Postmenopausal Women in the US
Favorite
8:00 AM – 6:00 PM
ADT
(091) Association between the use of different classes of blood pressure-lowering drugs and risk of incident dementia: a multi-database cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(093) Adherence patterns one year after initiation of Sodium-glucose cotransporter 2 inhibitors: a national cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(094) Plans Change: A Competing Risks Analysis of Time to Unplanned Stopping of Long-Term Outpatient Antibiotic Treatment, 2015-2022
Favorite
8:00 AM – 6:00 PM
ADT
(095) Phosphodiesterase Type 5 Inhibitors and The risk of Alzheimer’s Disease in Men with Erectile Dysfunction: A cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(096) N-Domain vs. C-Domain Angiotensin Converting Enzyme-inhibitors and the risk of Alzheimer's disease: A cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(097) Adverse Drug Reactions in an Ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
Favorite
8:00 AM – 6:00 PM
ADT
(098) Efficacy and safety of Mixed MAOB Inhibitors in Treatment of Adults with Parkinson's Disease: A Systematic Review and Meta-analysis
Favorite
8:00 AM – 6:00 PM
ADT
(099) Individual contributions of medications with anticholinergic side effects to high anticholinergic burden in older adults
Favorite
8:00 AM – 6:00 PM
ADT
(100) Trends in the Use and Costs of Benzodiazepines and Z-drugs in Canada from 2016 to 2022: a National Repeated Cross-Sectional Study
Favorite
8:00 AM – 6:00 PM
ADT
(101) Concurrent Use of Central Nervous System-Acting Medications and Risk for Inpatient Psychiatric and Skilled Nursing Facility Admission Among Young-onset Alzheimer’s Patients
Favorite
8:00 AM – 6:00 PM
ADT
(102) Trends in prevalence of polypharmacy and hyper-polypharmacy in the UK primary care: a population-based study from 1999 to 2018
Favorite
8:00 AM – 6:00 PM
ADT
(103) Medication Regimen Complexity and Family Caregiver Medication Administration Hassle in Home Hospice
Favorite
8:00 AM – 6:00 PM
ADT
(104) Association of physician characteristics and their competency on prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) among patients with congestive heart failure (CHF)
Favorite
8:00 AM – 6:00 PM
ADT
(105) Describing Adjuvant Chemotherapy Delivery in Older and Younger Women with Early-Stage Breast Cancer Using Longitudinal Cumulative Dose
Favorite
8:00 AM – 6:00 PM
ADT
(106) Association between antibiotics use and encephalopathies-related hospitalization among people living with dementia- a self-controlled case series study
Favorite
8:00 AM – 6:00 PM
ADT
(107) An investigation of psychoactive polypharmacy and related sex-differences in older adults with dementia
Favorite
8:00 AM – 6:00 PM
ADT
(108) Trends in Concurrent Use of Central Nervous System-Active Medications Among Young-onset Dementia Patients
Favorite
8:00 AM – 6:00 PM
ADT
(109) Potentially inappropriate prescribing and its association with adverse drug reaction-related hospital admissions
Favorite
8:00 AM – 6:00 PM
ADT
(110) Patterns of Antibiotic Prescribing for Urinary Tract Infections and Pneumonia by Provider Specialty in Nursing Home Care
Favorite
8:00 AM – 6:00 PM
ADT
(111) Who You Are And Where You Are Influences Antipsychotic Use in People with Dementia Living in Nursing Homes
Favorite
8:00 AM – 6:00 PM
ADT
(112) Pilot Project to Deprescribe Sedative-Hypnotic Drugs to Reduce Risk of Falls in Hospital Patients in Nova Scotia, Canada
Favorite
8:00 AM – 6:00 PM
ADT
(113) Trends in osteoporosis drug initiation and use among community dwelling older adults
Favorite
8:00 AM – 6:00 PM
ADT
(114) Potentially inappropriate medications among elderly patients in Chinese primary healthcare facilities: a nationwide survey, 2017-2019
Favorite
8:00 AM – 6:00 PM
ADT
(115) Drug-Drug Interactions and Adverse Drug Reaction Hospital Admissions in the Older Population: A Prospective Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(116) Is willingness enough? Willingness to deprescribe is not associated with changes in medication-related outcomes after one year
Favorite
8:00 AM – 6:00 PM
ADT
(117) Characteristics of seniors undergoing cognitive assessment or with a recent diagnosis of neurocognitive disorders in Quebec Family Medicine Groups in the GPS study
Favorite
8:00 AM – 6:00 PM
ADT
(118) Integrating Social Determinants of Health and Claims Data to Predict a Diagnosis of Depression Using the Medicare Current Beneficiary Survey
Favorite
8:00 AM – 6:00 PM
ADT
(119) Empowering the Elderly Patients: A Study on Impact of Virtual Patient Education on Medication Adherence
Favorite
8:00 AM – 6:00 PM
ADT
(120) Bipolar Disorder Treatment Changes After Nonfatal Suicide Attempt and Association with Subsequent Suicide Attempts: An Analysis of U.S. Veterans
Favorite
8:00 AM – 6:00 PM
ADT
(121) Trends in the prescription of anti-dementia treatments in Spain and the UK: a large network population-based cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(122) Long term Comparative Safety of ARNi verses ACEi/ARB: A Real-World Data analysis
Favorite
8:00 AM – 6:00 PM
ADT
(123) Disparity in guideline-based antidiabetic drugs prescribing for type 2 diabetes patients in primary healthcare facilities across China, 2017-2019
Favorite
8:00 AM – 6:00 PM
ADT
(124) Prescribing Trends of SGLT2 Inhibitors Among Patients with Heart Failure in the U.S., 2013-2020
Favorite
8:00 AM – 6:00 PM
ADT
(125) Validating birth proxy algorithms in Medicaid administrative claims
Favorite
8:00 AM – 6:00 PM
ADT
(126) Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)
Favorite
8:00 AM – 6:00 PM
ADT
(127) Anticoagulant Treatment and Thromboembolic Events Prior to Diagnosis of Renal Cell Carcinoma: Impact on Stage Distribution
Favorite
8:00 AM – 6:00 PM
ADT
(128) Real-World Patterns of Opioid Analgesic, Gabapentinoid, and Benzodiazepine Prescriptions in the United States: A Drug Utilization Study (2017-2021)
Favorite
8:00 AM – 6:00 PM
ADT
(129) Appropriate washout period for adverse events of special interest (AESI) in vaccine active surveillance utilizing an administrative claims database
Favorite
8:00 AM – 6:00 PM
ADT
(130) Association between mortality and warfarin comparing with direct oral anticoagulants: a population-based cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(131) Routine Clinical Use of PD-1/PD-L1 Immune Checkpoint Inhibitors and Survival in Patients With Advanced Cancers: A Danish Population-Based Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(132) Validated Algorithms to Identify Non-fatal Strokes using Uniform Objective Criteria: A Pooled Clinical Trial Data Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(133) Sensitivity Analyses to Assess Robustness of Estimates from Propensity Score Weighting in the Presence of Extremely Large Weights
Favorite
8:00 AM – 6:00 PM
ADT
(134) Predictors of Opioid Use Before and After Orthopaedic Surgery in an Australian Setting: A Multicentre, Cross-Sectional, Observational Study
Favorite
8:00 AM – 6:00 PM
ADT
(135) Use Of Baclofen For The Treatment Of Alcohol Use Disorders Between 2014 And 2021 In France
Favorite
8:00 AM – 6:00 PM
ADT
(136) Secular Trends and Determinants of Hepatitis C Virus Testing during Pregnancy
Favorite
8:00 AM – 6:00 PM
ADT
(137) Trends in the Utilisation of Antiepileptic Drugs Following Ischaemic Stroke
Favorite
8:00 AM – 6:00 PM
ADT
(138) Evaluating the Application of a Claims-Based Frailty Algorithm in Younger Adults in the US
Favorite
8:00 AM – 6:00 PM
ADT
(141) Comorbidity clusters before and after adjuvant endocrine therapy in oldest-old women with breast cancer: An unsupervised machine learning approach
Favorite
8:00 AM – 6:00 PM
ADT
(142) Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Dementia in People with Type 2 Diabetes (T2D): A Population-Based Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(143) Polypharmacy's association to mortality: A methodological case study
Favorite
8:00 AM – 6:00 PM
ADT
(144) Hip fracture incidence and post-fracture mortality in Victoria, Australia from 2012 to 2018
Favorite
8:00 AM – 6:00 PM
ADT
(145) The European Drug-Drug Interaction (EuroDDI) study protocol: a cross country comparison of the prevalence of drug-drug interactions in the older community-dwelling population
Favorite
8:00 AM – 6:00 PM
ADT
(146) The association of gabapentin initiation and neurocognitive changes in non-demented older adults with cognitive symptoms
Favorite
8:00 AM – 6:00 PM
ADT
(147) Liraglutide and Risk of Dementia: Real World Evidence
Favorite
8:00 AM – 6:00 PM
ADT
(148) Health Care Utilization and Medical Costs in New Users of Once-weekly GLP-1 RAs Compared with New Users of DPP-4is Among Individuals with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Favorite
8:00 AM – 6:00 PM
ADT
(149) Effect of Dipeptidyl Peptidase-4 Inhibitors on Fracture Risk in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials
Favorite
8:00 AM – 6:00 PM
ADT
(150) Comparative Effectiveness of Pegcetacoplan (PEG) Versus Ravulizumab (RAV) and Eculizumab (ECU) in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Matching-Adjusted Indirect Comparison
Favorite
8:00 AM – 6:00 PM
ADT
(151) PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern
Favorite
8:00 AM – 6:00 PM
ADT
(152) Budget impact of risperidone for adults with Autistic Spectrum Disorder in Brazil: a comparative analysis study between epidemiological demand and real-world data
Favorite
8:00 AM – 6:00 PM
ADT
(153) The Bendroflumethiazide versus Indapamide Study for hypertensiON (BISON) cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(154) Outpatient Cost of Care among Patients with Colorectal Cancer (CRC) Treated in the Real-World US Community Oncology Setting
Favorite
8:00 AM – 6:00 PM
ADT
(155) Cost-Effectiveness of Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma in Canada
Favorite
8:00 AM – 6:00 PM
ADT
(156) Anatomical Characterization of Long Bone Femur and Tibial Fractures and Associated Two-Year Risks of Non-Union – A US Database Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(157) Unveiling the impact of Digital Health Interventions in Coronary Heart Disease: A Systematic review and Meta-analysis
Favorite
8:00 AM – 6:00 PM
ADT
(158) Real-world Outpatient Cost of Care among Patients with Ovarian Cancer (OC) Treated in the US Community Oncology Setting
Favorite
8:00 AM – 6:00 PM
ADT
(159) The Effect of Allopurinol and Febuxostat on Blood Pressure in Adults with Chronic Hyperuricemia
Favorite
8:00 AM – 6:00 PM
ADT
(160) Trends of Myocarditis/Pericarditis following SARS-CoV-2 Infection: A Real-World Analysis of a Large US Commercial Claims Database Enriched with Ambulatory EMR Data
Favorite
8:00 AM – 6:00 PM
ADT
(161) Real-world Outpatient Cost of Care among Patients with Breast Cancer Treated in the US Community Oncology Setting
Favorite
8:00 AM – 6:00 PM
ADT
(162) Economic Burden of Gallbladder Cancer in Northeast India: A Hospital-based Prospective Observational Cost-analysis Study
Favorite
8:00 AM – 6:00 PM
ADT
(163) Quality of Life of Patients with Mild Cognitive Impairment or Alzheimer's Disease and Their Caregivers in the United States
Favorite
8:00 AM – 6:00 PM
ADT
(164) Real-world studies evaluating patients with HER2-low breast cancer: A systematic review and meta-analysis
Favorite
8:00 AM – 6:00 PM
ADT
(165) Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction between Asian and White Patients: A Meta-Analysis of Randomized Outcomes Trials
Favorite
8:00 AM – 6:00 PM
ADT
(166) Clinical Outcomes and Treatment Pattern of Older Patients with Heart Failure Across Different Frailty Severity Status: a Nationwide Cohort Study of 38,843 Newly Hospitalized Heart Failure Patients
Favorite
8:00 AM – 6:00 PM
ADT
(167) Lorlatinib in the first-line treatment of ALK-positive metastatic/advanced non-small-cell lung cancer: a budget impact analysis
Favorite
8:00 AM – 6:00 PM
ADT
(168) Analgesia Versus No-Analgesia in the Management of Neonates Undergoing Mechanical Ventilation in the Intensive Care Setting in Qatar. A Cost-Effectiveness Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(169) Association Between Trajectory of Metabolic Syndrome and Knee Pain over 11 Years in Middle-aged Adults: Evidence from Childhood Determinants of Adult Health (CDAH) Study
Favorite
8:00 AM – 6:00 PM
ADT
(170) Comparative Efficacy of Pharmacological Therapies for Heart Failure with Reduced Ejection Fraction: A Network Meta-Analysis of Randomized Controlled Trials
Favorite
8:00 AM – 6:00 PM
ADT
(171) Treatments and Healthcare Costs Associated with Long Bone Fracture Non-Union - A US Claims Database Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(172) Impact of Early palliative care on humanistic outcomes in patients with advanced cancer
Favorite
8:00 AM – 6:00 PM
ADT
(173) Risk Factors Associated with Long bone Fracture Non-Union – A US Claims Database Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(174) Prevalence of syphilis risk factors in Colorado from 2010-2020
Favorite
8:00 AM – 6:00 PM
ADT
(175) Burden of Narcolepsy from the Perspectives of Direct Medical Cost and Comorbidity in Japan
Favorite
8:00 AM – 6:00 PM
ADT
(176) Compare the generalizability of dapagliflozin and empagliflozin heart failure phase 3 trials to real-world patients in Taiwan
Favorite
8:00 AM – 6:00 PM
ADT
(177) Utilisation and Safety of IV Bolus Formulation of Akis® for use in the Prevention and Treatment of Post-operative Pain in the UK Secondary Setting
Favorite
8:00 AM – 6:00 PM
ADT
(178) Evaluation of Years of Potential Productive Life Lost (YPPLL) due to Premature Mortality from Head and Neck Cancer in Northeast India
Favorite
8:00 AM – 6:00 PM
ADT
(179) Utilization and evaluation of Drug therapy usage among neonates admitted to Neonatal Intensive Care Unit (NICU)
Favorite
8:00 AM – 6:00 PM
ADT
(180) Determination of patients’ quality of life (QOL) and its influencing risk factors associated with QOL in patients with autoimmune systemic vasculitis: a cross-sectional study
Favorite
8:00 AM – 6:00 PM
ADT
(181) Utilization of Comprehensive Metabolic Panels in Regular Patient Management: Investigation of Patient Follow-up Based on Abnormal Test results in a Claims Laboratory Test Result Database
Favorite
8:00 AM – 6:00 PM
ADT
(182) Characterizing Real-World Data Usage for Public Health Research
Favorite
8:00 AM – 6:00 PM
ADT
(183) Cost-effectiveness analysis of ibuprofen versus indomethacin or paracetamol for the treatment of patent ductus arteriosus in preterm neonates
Favorite
8:00 AM – 6:00 PM
ADT
(184) Management of cardiovascular risk in women with and without menopausal symptoms: a real-world depiction of clinical practice in the UK and France
Favorite
8:00 AM – 6:00 PM
ADT
(185) Personalize My Treatment (PMT): The First Pan-Canadian Cancer Patient Databank Suitable for Generation of Oncology Real-World Insights
Favorite
8:00 AM – 6:00 PM
ADT
(186) Cost‑effectiveness evaluation of add‑on dapagliflozin for heart failure with reduced ejection fraction among patients without type 2 diabetes
Favorite
8:00 AM – 6:00 PM
ADT
(187) Comparing immunocompromised status algorithms: Implications for outcomes and clinical trial enrollment
Favorite
8:00 AM – 6:00 PM
ADT
(188) Identifying Cytokine Release Syndrome in Retrospective Databases: A Performance Assessment of a Claims-Based Algorithm
Favorite
8:00 AM – 6:00 PM
ADT
(189) Assessment of medication adherence and the impact of clinical pharmacist interventions on medication adherence among systemic lupus erythematosus patients: a prospective cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(190) Representativeness of race and ethnicity in Real World Data: a comparison by disease type
Favorite
8:00 AM – 6:00 PM
ADT
(191) The Association Between Credit Risk Score and Major Depressive Disorder Burden Using Observed and Estimated PHQ-9 in a Real-World Cohort
Favorite
8:00 AM – 6:00 PM
ADT
(192) Linear Weighting to Improve Representativeness of Patients with Type 2 Diabetes Mellitus in US Electronic Health Records
Favorite
8:00 AM – 6:00 PM
ADT
(193) Patterns of Initiation and Discontinuation of Medications for Opioid Use Disorder in Commercially Insured Individuals in the US
Favorite
8:00 AM – 6:00 PM
ADT
(194) Sex-Specific Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation - A Systematic Review and Meta-Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(195) Ten-year landscape analysis of clinical research in Latin America: Only 6% of clinical trials make their results public
Favorite
8:00 AM – 6:00 PM
ADT
(196) Racial disparities in medicine use during pregnancy: results from the NISAMI cohort
Favorite
8:00 AM – 6:00 PM
ADT
(197) Impact of State-Level Abortion Hostility on Mifepristone Uptake Among an Employer-Insured Population, 2010-2020
Favorite
8:00 AM – 6:00 PM
ADT
(198) Urban-Rural Differences in Mortality among Patients Receiving Buprenorphine for Opioid Use Disorder Treatment in Kentucky
Favorite
8:00 AM – 6:00 PM
ADT
(199) Comparison of sociodemographic factors, health care utilisation by general practitioner visits and somatic hospital admissions, and medication use in Norway, Sweden, and Denmark
Favorite
8:00 AM – 6:00 PM
ADT
(200) The Cascade of Care in Individuals Screened for Hepatitis C Virus Infection in Emergency Departments
Favorite
8:00 AM – 6:00 PM
ADT
(202) Describing trends in hypertension-diabetes comorbidity in United States adults from 2008 to 2022 using Real World Data
Favorite
8:00 AM – 6:00 PM
ADT
(204) The Association Between Social Determinants of Health and 1-Year Survival Among Patients with Heart Failure in a Real-World Cohort
Favorite
8:00 AM – 6:00 PM
ADT
(205) Use of the web to promote antimicrobial stewardship–implementation of national AMR action plans, 2021
Favorite
8:00 AM – 6:00 PM
ADT
(206) The role of gender in health inequality; will methodological standardization close this gap? Results from a pragmatic review
Favorite
8:00 AM – 6:00 PM
ADT
(207) Clinical Characteristics of Patients with Different Types of Psoriasis In Optum Market Clarity Data
Favorite
8:00 AM – 6:00 PM
ADT
(208) Relationship between access to medicines in the unified health system and users' perception of health in the context of the national survey on access, use and promotion of the rational use of medicines
Favorite
8:00 AM – 6:00 PM
ADT
(209) Assessing “neglected populations” in clinical trials – a pilot study of asthma medication use
Favorite
8:00 AM – 6:00 PM
ADT
(210) Trends in Racial Disparities for Total Knee Arthroplasty — a US Hospital Database Analysis, 2000 – 2021
Favorite
8:00 AM – 6:00 PM
ADT
(211) Racial/ethnic differences in mental health service use and unmet need for treatment among US adults with a past-year major depressive episode in the 2020 National Survey on Drug Use and Health Data
Favorite
8:00 AM – 6:00 PM
ADT
(212) Effect of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool
Favorite
8:00 AM – 6:00 PM
ADT
(213) Generating synthetic cohorts of real-world patients with metastatic breast cancer to accelerate collaboration
Favorite
8:00 AM – 6:00 PM
ADT
(214) A Systematic Literature Review of Current Application of Machine Learning for Patient Phenotyping and Selection in Observational Studies
Favorite
8:00 AM – 6:00 PM
ADT
(215) Examining misclassification differences for myocardial infarction and angioedema between drug exposures
Favorite
8:00 AM – 6:00 PM
ADT
(217) Development of Computable Operational Definitions to Maximize Comparability & Consistency Across a Multi-Data Source Global Real-World Effectiveness Program
Favorite
8:00 AM – 6:00 PM
ADT
(218) Methodological challenges for single- vs polydrug classification of drug overdose deaths
Favorite
8:00 AM – 6:00 PM
ADT
(219) Development of Audit Readiness Considerations of Real-World Data for Use in Regulatory Decision-Making
Favorite
8:00 AM – 6:00 PM
ADT
(220) The Utility and Versatility of Linked Database in HIV Care for tracking Vertical Transmission of HIV in the Western Cape Province in South Africa
Favorite
8:00 AM – 6:00 PM
ADT
(221) Methods in Dynamic Treatment Regimens using Observational Data: A Systematic Review
Favorite
8:00 AM – 6:00 PM
ADT
(222) Evaluation of tokenization using a large claims and medical records dataset in patients with hemophilia B
Favorite
8:00 AM – 6:00 PM
ADT
(223) Evaluation of the completeness of a medical record dataset linked to administrative claims through tokenization in patients with hemophilia B
Favorite
8:00 AM – 6:00 PM
ADT
(224) Sub-Analyses, Post-Hoc Analyses and Full Publication Rate: Are we Potentially Missing Important Evidence?
Favorite
8:00 AM – 6:00 PM
ADT
(225) Bibliometric Analysis Based on Abstracts of the 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Favorite
8:00 AM – 6:00 PM
ADT
(226) Data Stewardship and its Role in Ensuring Real-World Data Quality and Methodological Rigor in Research
Favorite
8:00 AM – 6:00 PM
ADT
(227) Severity and burden of sickle cell disease (SCD) in France: a nationwide real-world study
Favorite
8:00 AM – 6:00 PM
ADT
(228) Development of a risk categorization framework to quantify antimicrobial resistance risk in female patients with uncomplicated urinary tract infection
Favorite
8:00 AM – 6:00 PM
ADT
(229) Artificial intelligence applied: data-driven vector representations of adverse events and drugs in pharmacovigilance
Favorite
8:00 AM – 6:00 PM
ADT
(230) Risk of Electrolyte Imbalance in Elderly Colorectal Cancer Patients Following Treatment with Metformin Vs Sulfonylureas
Favorite
8:00 AM – 6:00 PM
ADT
(231) Bespoke Code vs. Off-the-shelf R Package in Calculating Incidence Rates Using Real-World Data
Favorite
8:00 AM – 6:00 PM
ADT
(232) Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population
Favorite
8:00 AM – 6:00 PM
ADT
(233) Identification of Unrecognized Associations Between Medications and Gastrointestinal Bleeding by Screening Large Administrative Health Data
Favorite
8:00 AM – 6:00 PM
ADT
(234) Developing a perinatal extension for the OMOP common data model
Favorite
8:00 AM – 6:00 PM
ADT
(235) Characterizing Disease Progression in Multiple Sclerosis Subtypes Using RWD: Feasibility of Applying a Machine Learning Model to Address Missing Data
Favorite
8:00 AM – 6:00 PM
ADT
(236) New Approaches for Linking Mother and Infant Data using Electronic Medical Records Data
Favorite
8:00 AM – 6:00 PM
ADT
(237) Lift Off: From Real World Data Quality Guidelines to Actionable Assessment
Favorite
8:00 AM – 6:00 PM
ADT
(239) Novel Data and Lag-times within the EHR Provided by the Long-Term Care Data Cooperative (LTCDC)
Favorite
8:00 AM – 6:00 PM
ADT
(240) Characterization of Real World data sources for pharmacoepidemiological studies in pregnancy and lactation: the ConcePTION project
Favorite
8:00 AM – 6:00 PM
ADT
(241) Unlocking the patient journey: comparing machine learning (ML) based natural language processing (NLP) and expert abstraction in understanding treatment patterns
Favorite
8:00 AM – 6:00 PM
ADT
(243) Feasibility Assessment of a Real-world Clinico-genomics Dataset in Non-small Cell Lung Cancer (AACR GENIE BPC)
Favorite
8:00 AM – 6:00 PM
ADT
(245) Evaluation of Handling Degrees of Missingness in the Features of Machine Learning Algorithms to Predict Overall Survival Using Real-World Lung Cancer Data
Favorite
8:00 AM – 6:00 PM
ADT
(246) Real-world evidence on the burden of known side-effects of typical and atypical antipsychotic medications in patients with schizophrenia
Favorite
8:00 AM – 6:00 PM
ADT
(247) Validating Type II Diabetes Case Definitions in Electronic Health Records: A Comparison of Sensitivity and Specificity Using HbA1c as the Gold Standard
Favorite
8:00 AM – 6:00 PM
ADT
(248) A novel approach to secondary data studies in pregnancy leveraging linked EMRs linked under Health Information Exchanges in the Unites States
Favorite
8:00 AM – 6:00 PM
ADT
(249) Detecting digital illness threat using an anomaly detection approach in the United States
Favorite
8:00 AM – 6:00 PM
ADT
(251) NLP Detection of Mortality Information from Publicly Available Data using Deep Learning Modelling
Favorite
8:00 AM – 6:00 PM
ADT
(252) Assessing validity of privacy-preserving synthetic patient data: A use case utilizing Israel COVID-19 real-world vaccine effectiveness study
Favorite
8:00 AM – 6:00 PM
ADT
(253) An Emulated Target Trial Case Study of Real-World Overall Survival in Second-line Maintenance Niraparib vs Active Surveillance in Patients with Recurrent Ovarian Cancer
Favorite
8:00 AM – 6:00 PM
ADT
(254) Prevalence and prognosis of hypoxia-inducible factor-2α (HIF-2α) pathway gene mutations across tumor types
Favorite
8:00 AM – 6:00 PM
ADT
(255) Biomarkers Predictive of a Response to Extended Endocrine Therapy in Breast Cancer: A Systematic Review
Favorite
8:00 AM – 6:00 PM
ADT
(256) Dealing with time-varying treatments in observational studies: a qualitative methodological review and proposal of research framework
Favorite
8:00 AM – 6:00 PM
ADT
(258) Evaluating the impact of 5-HTTLPR on metformin response in type II diabetes patients in a longitudinal cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(259) Non-squamous, Metastatic Non-small Cell Lung Cancer: Retrospective c-Met Overexpression Testing, Patient Characteristics, and Treatment Patterns
Favorite
8:00 AM – 6:00 PM
ADT
(260) Characterizing the Distribution of Multiple Negative Control Outcome Risk Differences
Favorite
8:00 AM – 6:00 PM
ADT
(261) CARMA-BROS: An efficient Basket/Umbrella Real-world Observational Study (BUROS) Design for Rare Cancer Subtypes
Favorite
8:00 AM – 6:00 PM
ADT
(262) The diagnostic landscape of HRD testing based on cross-sectional survey of physicians and molecular biologists conducting testing (INDICATOR ONE)
Favorite
8:00 AM – 6:00 PM
ADT
(263) EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois: CONTACT: Recruiting and Engaging Participants
Favorite
8:00 AM – 6:00 PM
ADT
(265) Effect of CYP and NAT2 Gene Polymorphisms on Human Response to Artemisinin-Based Combination Therapies in Yaounde, Cameroon
Favorite
8:00 AM – 6:00 PM
ADT
(266) BMP8B: A beacon of hope for a non-invasive diagnostic biomarker of NAFLD progression
Favorite
8:00 AM – 6:00 PM
ADT
(267) Unbalanced microbial genomic sequences from East Africa limits global surveillance for antimicrobial resistance in non-typhoidal Salmonella
Favorite
8:00 AM – 6:00 PM
ADT
(268) Issues of statine utilisation
Favorite
8:00 AM – 6:00 PM
ADT
(269) Integration of Basket/Umbrella Real-world Observational Studies (BUROS) into International Epidemiological Consortia to Inform Cancer Clinical Course and Disease Epidemiology
Favorite
8:00 AM – 6:00 PM
ADT
(270) Building Fit-For-Purpose Real-World Clinicogenomic Data in Aesthetics for Personalized Skin Care Goals
Favorite
8:00 AM – 6:00 PM
ADT
(271) Interferon-beta exposure in-utero and the risk of infections
Favorite
8:00 AM – 6:00 PM
ADT
(272) Changes in Pediatric Emergency Department Visits and Hospitalizations for Unintentional Exposures to Oral Prescription Medications in the United States, 2010-2021
Favorite
8:00 AM – 6:00 PM
ADT
(273) Validation of ICD-9- and ICD-10-based Diagnostic Algorithms for Juvenile Idiopathic Arthritis within a Large U.S. Commercial Claims Database
Favorite
8:00 AM – 6:00 PM
ADT
(275) Sex-specific prevalences of psychotropic medication in pediatric populations from DK and US: 2010-2020
Favorite
8:00 AM – 6:00 PM
ADT
(276) Medical cannabis related drug-drug interactions in children: A systematic review
Favorite
8:00 AM – 6:00 PM
ADT
(277) Sociodemographic and birth characteristics associated with initiation of methylphenidate treatment in children: a nationwide study from 2015 to 2022
Favorite
8:00 AM – 6:00 PM
ADT
(278) Utilisation and safety of Glycopyrronium Bromide 1mg/5ml oral solution for sialorrhoea in the paediatric population in the UK: Interim results from a non-interventional post authorisation safety study
Favorite
8:00 AM – 6:00 PM
ADT
(279) First-Line Treatments for Infantile Spasms: A GRADE Analysis of Umbrella Review of Systematic Reviews and Meta-Analyses
Favorite
8:00 AM – 6:00 PM
ADT
(280) Comparison of presepsin and interleukin 6 for the diagnosis of neonatal sepsis: a systematic review and meta-analysis
Favorite
8:00 AM – 6:00 PM
ADT
(282) Pediatric observational effectiveness evaluation studies in the EU PAS Register: What can we learn from study characteristics?
Favorite
8:00 AM – 6:00 PM
ADT
(284) Trend analysis of medication label prediction model based on real-world pediatric drug database
Favorite
8:00 AM – 6:00 PM
ADT
(285) Real-world Data Evaluating Safety, Effectiveness and Dosing of Dalteparin for the Treatment of Venous Thromboembolism (VTE) in Neonates Aged 0 to 28 days
Favorite
8:00 AM – 6:00 PM
ADT
(286) Accuracy of ICD-10 Diagnosis Codes for Identifying Influenza Illness Among Children in the Emergency Department and Hospital Settings
Favorite
8:00 AM – 6:00 PM
ADT
(287) Assessing neonatal outcome misclassification using mother-infant dyad claims
Favorite
8:00 AM – 6:00 PM
ADT
(B01) Adherence and persistence to cardiovascular medicines in Australia among people initiating therapy in 2018
Favorite
8:00 AM – 6:00 PM
ADT
(B02) Adherence to hypoglycemic medications among pregnant patients with gestational diabetes
Favorite
8:00 AM – 6:00 PM
ADT
(B03) Cost-Related Nonadherence Among Adults with Multiple Chronic Conditions in the US from 2013 to 2021
Favorite
8:00 AM – 6:00 PM
ADT
(B04) Direct Medical Cost Associated with Antiplatelet Non-persistence in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention
Favorite
8:00 AM – 6:00 PM
ADT
(B05) Effectiveness of Medication Therapy Management in Older Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Favorite
8:00 AM – 6:00 PM
ADT
(B06) Evaluate Medication Adherence Classes using Latent Mixed Model
Favorite
8:00 AM – 6:00 PM
ADT
(B07) Exploring Real-life Persistence with Denosumab (Prolia®): A 7-year-follow-up Study In Spain
Favorite
8:00 AM – 6:00 PM
ADT
(B08) Older adults’ adherence to medications and willingness to deprescribe: A sub-study of a randomized clinical trial
Favorite
8:00 AM – 6:00 PM
ADT
(B09) A Hospital-Based Cohort Study on Drug-Related Problems Associated with High-Risk Medications Amongst Special Populations
Favorite
8:00 AM – 6:00 PM
ADT
(B10) Comparison of common protocol vs. common data model and the issues of analytic inconsistency for a multi-database pharmacoepidemiologic study
Favorite
8:00 AM – 6:00 PM
ADT
(B11) Comparisons of non-vitamin K antagonist oral anticoagulants and warfarin for incident depressive disorders in patients with atrial fibrillation: A nationwide cohort study using target trial emulation framework
Favorite
8:00 AM – 6:00 PM
ADT
(B12) Effect of Bisphosphonates versus Denosumab on Risks of Cardiovascular Events in Patients with Type 2 Diabetes
Favorite
8:00 AM – 6:00 PM
ADT
(B13) Evaluation Suboptimal Outcomes in Crohn's Disease Patients with Biologic Treatment
Favorite
8:00 AM – 6:00 PM
ADT
(B14) Risk of Ischemic or Hemorrhagic Retinopathy and Anticholinergic Burden in Elderly Patient in Taiwan: A Case-Crossover Study
Favorite
8:00 AM – 6:00 PM
ADT
(B15) Use of Different Antihypertensive Drugs and Risk of Intradialytic Hypotension in Patients Undergoing Hemodialysis
Favorite
8:00 AM – 6:00 PM
ADT
(B16) Immunization Status of the 23-Valent Pneumococcal Polysaccharide Vaccine among Elderly Aged 65 and Older in South Korea
Favorite
8:00 AM – 6:00 PM
ADT
(B17) Comparison of biologic use in pivotal clinical trials vs. real-world setting with immune-mediated inflammatory diseases: an Italian population-based study from the VALORE project
Favorite
8:00 AM – 6:00 PM
ADT
(B18) Comparison of Serious Infections between Biosimilar and Bio-Originator Initiators in Canada: Population-Based Analyses
Favorite
8:00 AM – 6:00 PM
ADT
(B19) Disease severity profile and treatment switch patterns as treatment response proxy in Crohn’s disease population using Optum databases
Favorite
8:00 AM – 6:00 PM
ADT
(B20) Impact of COVID Lock-down on Adherence to Romosozumab Among US Post-menopausal Women Enrolled in Medicare
Favorite
8:00 AM – 6:00 PM
ADT
(B21) Joint pain in patients with atopic dermatitis receiving treatment with dupilumab in a nation-wide cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(B23) Rates of Intraocular Inflammation Following Intravitreal Aflibercept Prefilled Syringe and Vial Injections in US Clinical Practice, 2014-2022
Favorite
8:00 AM – 6:00 PM
ADT
(B24) Risk of Venous Thromboembolism with Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review
Favorite
8:00 AM – 6:00 PM
ADT
(B25) A Digital Toolkit to Contextualise and Visualise the Benefit and Risk of COVID-19 Vaccines in the European Union
Favorite
8:00 AM – 6:00 PM
ADT
(B26) Assessment of the U.S. Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) for Prasugrel (Effient)
Favorite
8:00 AM – 6:00 PM
ADT
(B27) Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials
Favorite
8:00 AM – 6:00 PM
ADT
(B28) Physician Knowledge of Safe Use of Cyproterone Acetate Monotherapies and Meningioma
Favorite
8:00 AM – 6:00 PM
ADT
(B29) The Use of Statins for the Primary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes: A Quantitative Benefit-Risk Analysis
Favorite
8:00 AM – 6:00 PM
ADT
(B30) Utility of Healthcare Professional (HCP) Surveys for Evaluating the Effectiveness of Additional Risk Minimization Measures (aRMMs): Experience from an HCP Survey Assessing the Effectiveness of aRMMs for Xeljanz® in Europe
Favorite
8:00 AM – 6:00 PM
ADT
(B31) What are patient with non-small cell lung cancer (NSCLC) preferences regarding treatment?
Favorite
8:00 AM – 6:00 PM
ADT
(B32) What do we know on patient preferences for treatment of multiple sclerosis?
Favorite
8:00 AM – 6:00 PM
ADT
(B34) Examining the risk of COVID-19 among cancer patients and comparing it with the Swedish general population: A register-based cohort study within the SCIFI-PEARL project
Favorite
8:00 AM – 6:00 PM
ADT
(B35) Glucagon Like Peptide-1 Receptor Agonists and the Risk of Skin Cancer Among Patients with Type 2 Diabetes: Population-Based Cohort Study
Favorite
8:00 AM – 6:00 PM
ADT
(B36) Predicting HER2 Status in Non-Small Cell Lung Cancer using Machine Learning Approach for Precision Cancer Pharmacoepidemiology in Large Databases
Favorite
8:00 AM – 6:00 PM
ADT
(B37) Predictive Biomarkers for PD-1/PD-L1 Checkpoint Inhibitor Response in NSCLC – an Analysis of Clinical Trial and Real-world Data
Favorite
8:00 AM – 6:00 PM
ADT
(B39) Trends in New and Persistent Opioid Use in Older Adults with Cancer
Favorite
8:00 AM – 6:00 PM
ADT
(B40) When does the clock start ticking? Deriving the date of cancer diagnosis from electronic health record data
Favorite
8:00 AM – 6:00 PM
ADT
(B41) A Framework for Considering Regulatory Likelihood of Acceptance of a Single-Arm Trial
Favorite
8:00 AM – 6:00 PM
ADT
(B42) A retrospective cohort study of Gaucher Disease Type 1 to describe sub-optimal responders to standard of care treatments in the United States
Favorite
8:00 AM – 6:00 PM
ADT
(B43) A systematic review of the efficacy of sirolimus and methotrexate after hematopoietic stem cell transplantation
Favorite
8:00 AM – 6:00 PM
ADT
(B44) Assessing Risk of Bias in Comparative Effectiveness Studies of Chimeric Antigen Receptor T-Cell Therapies for Relapsed or Refractory Large B-Cell Lymphoma
Favorite
8:00 AM – 6:00 PM
ADT
(B45) Feasibility of Assessing Comparative Long-Term Safety for Gene Therapy Products by Creating an External Control Arm using Real-World Data Sources
Favorite
8:00 AM – 6:00 PM
ADT
(B46) Maximising the use of real-world data from multiple sources to generate comprehensive evidence: insights from retrospective cohorts of allogeneic hematopoietic cell transplant recipients with adenovirus infection
Favorite
8:00 AM – 6:00 PM
ADT
(B47) Cardiovascular risk stratification in patients with type 2 diabetes
Favorite
8:00 AM – 6:00 PM
ADT
(B48) Causal forests vs Inverse probability weighting for addressing cluster-level confounding in medical device and surgical epidemiology: A simulation study
Favorite
8:00 AM – 6:00 PM
ADT
(B49) Comparative cardiovascular effectiveness of liraglutide 3 mg
Favorite
8:00 AM – 6:00 PM
ADT
(B50) Comparing approaches to achieving exact balance on key covariates in propensity score matched analyses: a simulation study
Favorite
8:00 AM – 6:00 PM
ADT
(B51) Immortal time bias arising from inappropriate anchor of outcome event date
Favorite
8:00 AM – 6:00 PM
ADT
(B52) Preventing Heart Failure Admissions with Sodium-Glucose Cotransporter-2 Inhibitors versus Angiotensin Receptor-Neprilysin Inhibitors: A Target Trial Emulation Study
Favorite
8:00 AM – 6:00 PM
ADT
(B53) Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population-based cohort study
Favorite
8:00 AM – 6:00 PM
ADT
(B54) Variance Estimation of the Risk Difference When Using Propensity-Score Matching and Weighting with Time-To-Event Outcomes
Favorite
